Developer docs
API playgroundTry for free, no card

Search company profiles

PBS Biotech

Full company profile

uuid0000rd9

Namestring
PBS Biotech
Legal namestring
PBS Biotech, Inc.
Websiteurl
pbsbiotech.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

PBS Biotech, Inc., founded in 2006 and headquartered in Camarillo, California, designs and manufactures single-use bioreactor systems based on its patented Vertical-Wheel impeller technology for the cell therapy industry. The platform uses a vertically-oriented, bi-directional impeller rotating via magnetic coupling around a fixed shaft to deliver low-shear, homogeneous mixing that is CFD-validated (ANSYS Fluent, MStar, STAR-CCM+) to scale linearly from 60mL to 80L across the PBS-Mini 0.1, PBS-Mini 0.5, MiniPRO (multi-parallel), PBS-3, PBS-15, and PBS-80 product family. Products are assembled in-house at a 63,800 sq. ft. ISO 9001:2015 facility, with single-use vessels gamma-irradiated and product-contact materials meeting USP Class VI / ISO 10993; the proprietary Hello UI software supports 21 CFR Part 11 cGMP requirements. Named end users include the University of Alberta, GeneFab, RoosterBio, and the Alberta Diabetes Institute, spanning iPSC, MSC, NK, and T-cell applications.

The company sells hardware on a quote-based enterprise motion to biopharmaceutical companies, CDMOs, and academic researchers, complemented by recurring consumables (single-use vessels, sensors, perfusion vessels, accessories) and professional services including Success Bundle consulting, 4-6 month contract process development engagements, and field service/IQ-OQ qualification. Pricing is anchored by Starter Packs publicly listed at $7,250 (Basic) to $18,750 (Premium) for 0.1L systems, with savings of 39-43% versus unbundled list, plus a Credit Redemption Program that awards 1 credit per $1 spent on PBS-Mini products (2023-2026) redeemable toward MiniPRO, PBS-3, or Success Bundles. GTM combines direct field sales (Sr. VP Global Sales, CCO) with an e-commerce storefront at shoppbsbiotech.com, supported by an Applications Engineering team and a multi-channel content marketing program (webinars, case studies, posters, conference presence at ISSCR, ISCT, ARM Meeting on the Mesa). Strategic partnerships include co-development integrations with Repligen (XCell ATF), GeneFab, STEMCELL Technologies, denovoMATRIX, CellGenix, and Masterflex, alongside financial backers Avego Management and BroadOak Capital Partners (cumulative disclosed equity approximately $57.5M across 2021, 2023, 2024, and 2025 rounds).

Short descriptiontext

PBS Biotech manufactures single-use Vertical-Wheel bioreactor systems (60mL to 80L) and provides process development services for cell therapy developers, CDMOs, and academic researchers, enabling scalable manufacturing of iPSCs, MSCs, NK cells, and T cells.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCamarillo, United States
HQ citystring
Camarillo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
single-use bioreactors, cell therapy manufacturing, bioprocess equipment, process development services, vertical-wheel mixing
Industry3 codes
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAA
Cell Therapy CDMO (Autologous/Allogeneic Manufacturing)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Commercial Physical & Biological Research8731
Product category
Single-Use Bioreactors for Cell Therapy Bioprocessing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Single-Use Bioreactor Hardware Systems
TypeHardware Sales
Description

Sale of reusable electromechanical bioreactor housing units (Base Unit for PBS-Mini; instrument units for PBS-3, PBS-15, PBS-80). Hardware is sold directly to biopharma companies and CDMOs for cell therapy manufacturing. Price points vary by scale; quote-based pricing with publicly listed Starter Pack options starting at $7,250.

pbsbiotech.com
2Single-Use Vessels and Consumables
TypeHardware Sales
Description

Recurring revenue from single-use bioreactor vessels (gamma-irradiated, double-bagged), perfusion vessels, sensors (single-use and reusable), accessories, and filters. Purchased alongside hardware systems and replenished regularly. PBS-Mini generates 1 credit per $1 spent redeemable toward larger systems.

pbsbiotech.com
3Process Development (CDO) Services
TypeProfessional Services
Description

Contract process development services provided by Bioprocess Research & Development team using state-of-the-art onsite laboratory. Services include cell culture process development, optimization, scale-up, and characterization for iPSCs, MSCs, NK cells, T cells, and other therapeutic cell types. Typical contract duration 4-6 months. Supports customers from R&D through first-in-human clinical studies.

pbsbiotech.com
4Success Bundles (Consulting Packages)
TypeProfessional Services
Description

Personalized consulting packages (Basic, Enhanced, Premium) bundled with Starter Pack purchases or sold separately. Includes remote support, data analysis, process optimization guidance, and on-site application engineering visits. Credits earned through PBS-Mini purchases can be redeemed toward Success Bundles, PBS-3, or MiniPRO bioreactors.

pbsbiotech.com
5Field Service and Qualification
TypeProfessional Services
Description

System installation, preventative maintenance, onsite support, instrument repair, IQ/OQ qualification protocols, software upgrades, and hardware conversions provided by Applications Engineers. Service Plans offered for MiniPRO, PBS-3, PBS-15, and PBS-80 bioreactors.

pbsbiotech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Pricing details7 tiers
1Basic Starter Pack — $7,250 (0.1L) / $7,560 (0.5L), saving 39% vs. $11,950/$12,310 list price
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes 1 PBS-Mini Bioreactor Base Unit, 1 Pack of 4 Single-Use Vessels (choose 0.1L or 0.5L), Basic Success Bundle (6 remote 2-hour meetings, data analysis, access to PBS Bioprocess Research Team). 39% savings compared to purchasing components separately.

pbsbiotech.com
2Enhanced Starter Pack — $13,000 (0.1L) / $13,620 (0.5L), saving 41-42% vs. $22,400/$23,120 list price
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes 2 PBS-Mini Bioreactor Base Units, 2 Packs of 4 Single-Use Vessels, Enhanced Success Bundle (Basic + one 3-day site visit by PBS Applications Engineer). 41-42% savings. Travel surcharge applies outside US & Canada.

pbsbiotech.com
3Premium Starter Pack — $18,750 (0.1L) / $19,680 (0.5L), saving 42-43% vs. $32,850/$33,930 list price
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Includes 3 PBS-Mini Bioreactor Base Units, 3 Packs of 4 Single-Use Vessels, Premium Success Bundle (Enhanced + one additional site visit midway through plan). 42-43% savings. Travel surcharge applies outside US & Canada.

pbsbiotech.com
4Basic Success Bundle standalone — bundled pricing available when purchased with Starter Pack
ModelUnit PricingBilling cadencePay-as-you-go
Notes

6 remote 2-hour meetings, data analysis and optimization guidance, custom reports, access to PBS Bioprocess Research Team for complex issues. Remote-only support.

pbsbiotech.com
5Enhanced Success Bundle standalone — bundled pricing available when purchased with Starter Pack
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Everything in Basic plus one 3-day site visit with PBS Applications Engineer covering setup, inoculation, media exchange, sampling. Travel surcharge outside US & Canada.

pbsbiotech.com
6Premium Success Bundle standalone — bundled pricing available when purchased with Starter Pack
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Everything in Enhanced plus one additional site visit midway through plan for in-depth process optimization and troubleshooting. Travel surcharge outside US & Canada.

pbsbiotech.com
7Individual Bioreactor Systems — quote-based pricing
ModelUnit PricingBilling cadenceMulti-year contract
Notes

All individual product SKUs (PBS-Mini Base Unit, PBS-3, PBS-15, PBS-80 bioreactors, perfusion vessels, accessories) sold via quote request. 90-day money-back guarantee on PBS-Mini products with performance documentation.

pbsbiotech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PBS Biotech designs, manufactures, and sells single-use bioreactor systems based on its patented Vertical-Wheel impeller technology for the cell therapy industry, with working volumes spanning 60 mL to 80 L across the PBS-Mini, MiniPRO, PBS-3, PBS-15, and PBS-80 product families. The company also provides contracted process development (CDO) services, Success Bundle consulting packages, and field service to support customers scaling cell therapies from R&D through commercial manufacturing.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PBS Biotech offers a scalable Vertical-Wheel bioreactor platform for cell therapy manufacturing spanning from 0.1L to 80L working volumes. The product family includes PBS-Mini (0.1 and 0.5L) for early-stage process development, MiniPRO for high-throughput parallel development, PBS-3 (3L) for mid-scale development and early clinical trials, PBS-15 (15L) for clinical stage production, and PBS-80 (80L) for commercial-scale manufacturing. All bioreactors share the proprietary Vertical-Wheel impeller technology enabling linear scalability and homogeneous mixing conditions. The platform is complemented by single-use vessels, perfusion accessories, Success Bundle consulting services, and contract process development (CDO) services for cell therapy optimization.

Product and service10 records
1PBS-Mini 0.1 Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Entry-level single-use bioreactor supporting 60 to 100 mL working volumes with Vertical-Wheel mixing, designed for early-stage cell therapy development and scale-up path to larger bioreactors. Used by cell therapy developers and academic researchers in incubator-controlled environments.

2PBS-Mini 0.5 Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Single-use bioreactor supporting 300 to 500 mL working volumes with a universal Base Unit and GMP-compliant materials for first-in-human clinical trials, designed for early-stage cell therapy development.

3PBS-MiniPRO Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Multi-parallel bioreactor platform enabling simultaneous control of up to 24 cultures with real-time monitoring in a closed system, designed for high-throughput cell therapy process development and scale-up using Vertical-Wheel technology.

4PBS-3 Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Mid-scale single-use bioreactor supporting 1.8 to 3 L working volumes with bioprocess control and monitoring capabilities, designed for bench-scale stem cell therapy process development and seamless transition from PBS-Mini.

5PBS-15 Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Large-scale single-use bioreactor supporting 9 to 15 L working volumes with Adjustable Height Harvest Valve (AHHV) for medium exchange, sampling, and harvest, designed for clinical and commercial-scale stem cell therapy production.

6PBS-80 Bioreactor
CategorySingle-Use Bioreactor Hardware
Description

Commercial-scale single-use bioreactor supporting 40 to 80 L working volumes with Adjustable Height Harvest Valve (AHHV), designed for large-scale cell therapy production with reproducible scale-up from PBS-Mini process conditions.

7PBS-Mini 0.5 Perfusion Single-Use Vessel
CategorySingle-Use Vessel / Consumable
Description

Single-use vessel with integrated 60 μm PSC Perfusion Filter for controlled perfusion-based PSC cultures, providing built-in cell retention with dedicated feed and waste lines for contamination-free continuous perfusion.

8PBS Starter Packs
CategoryBundled Solution
Description

Entry-level curated solutions bundling PBS-Mini bioreactor systems, single-use vessels (0.1 L or 0.5 L), and a Success Bundle consulting package across three tiers (Basic, Enhanced, Premium) at 39-43% savings versus component list price.

9Success Bundles
CategoryConsulting Services
Description

Personalized consulting packages with three tiers (Basic remote support, Enhanced remote plus one site visit, Premium remote plus two site visits) that provide data analysis, optimization guidance, and access to PBS Bioprocess Research Team.

10Process Development (CDO) Services
CategoryContract Process Development Services
Description

Contracted process development services covering cell thawing/inoculation, seed train optimization, 3D expansion, differentiation, medium exchange, harvest, downstream processing, analytics, and tech transfer using the company's Vertical-Wheel platform. Typical contract duration is 4-6 months.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership announced on STEMCELL Technologies press release for robust scale-up of human pluripotent stem cell 3D cultures. Combines STEMCELL's cell culture media and reagents expertise with PBS Biotech's Vertical-Wheel bioreactor platform for optimized PSC culture scale-up.

Strategic tierStrategicTypeTechnology or Integration
Description

Collaboration demonstrated in published CAR-NK cell expansion case study using PBS Vertical-Wheel Bioreactors with Repligen's XCell ATF perfusion technology. GeneFab contributed process development expertise and demonstrated closed-system workflow for NK cell expansion at 100mL and 3L working volumes.

Strategic tierStrategicTypeTechnology or Integration
Description

Partnership through XCell Alternating Tangential Flow (ATF2) filtration device integration with PBS Vertical-Wheel Bioreactors. Demonstrated in joint case study with GeneFab for CAR-NK cell expansion showing 2.6X greater cell yield with perfusion media exchange vs. fed-batch methods. Enables closed, scalable low-shear environment optimized for high-quality immune-cell production.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Lonza is a leading cell therapy CDMO whose process development services and proprietary bioreactor approaches compete for the same allogeneic and CDMO budgets PBS Biotech targets, while also being a potential customer for Vertical-Wheel systems within Lonza's manufacturing network.

TypeDirect peer
Description

Sartorius' Biostat RM and Biostat B single-use bioreactors are the closest large-scale competitors to PBS Biotech's Vertical-Wheel platform, with comparable single-use vessel design and overlapping cell therapy and biopharma customer base.

3Merck KGaA (MilliporeSigma)
TypeDirect peer
Description

MilliporeSigma's Mobius CellReady and Mobius bioreactor systems are direct competitors to PBS Biotech's single-use platform, often bundled with Merck's media, buffers, and filtration products for cell therapy customers.

TypeDirect peer
Description

Cytiva's Xuri W25 cell expansion system and single-use bioreactor portfolio directly compete with PBS Biotech in cell therapy manufacturing, offering similar scale-up functionality with a much larger global service network and broader bioprocess portfolio.

TypeDirect peer
Description

ABEC designs custom single-use bioreactors for cell therapy and viral vector applications at commercial scale, competing with PBS Biotech's PBS-15 and PBS-80 systems among larger allogeneic and CDMO customers.

TypeDirect peer
Description

Thermo Fisher's HyPerforma and Nunc single-use bioreactor systems (acquired largely via the Finesse and Patheon portfolios) compete head-to-head with PBS Biotech for cell therapy manufacturing capital equipment, bundled with the company's media, filters, and services.

TypeDirect peer
Description

Eppendorf's BioFlo 320 and BioFlo 120 bioreactor systems target process development and small-scale production for cell and gene therapy applications, overlapping with PBS-Mini and PBS-3 use cases among academic and biotech customers.

TypeEmerging player
Description

Cellexus offers the CellMaker single-use bioreactor system targeting cell and gene therapy process development, similar in scale and customer profile to PBS Biotech's PBS-Mini line, though with a smaller commercial footprint.

9Pall Corporation (Danaher)
TypeDirect peer
Description

Pall's Allegro STR single-use bioreactors and iCELLis fixed-bed systems compete with PBS Biotech in cell therapy and bioprocess applications, leveraging Pall's broader filtration and bioprocess consumables portfolio within Danaher.

TypeEmerging player
Description

Miltenyi Biotec offers the Prodigy and Cocoon closed-system cell processing platforms that overlap with PBS Biotech's process development and small-scale manufacturing value proposition for autologous and allogeneic cell therapy developers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PBS Biotech

Single-Use Bioreactors for Cell Therapy Bioprocessingpbsbiotech.com

PBS Biotech manufactures single-use Vertical-Wheel bioreactor systems (60mL to 80L) and provides process development services for cell therapy developers, CDMOs, and academic researchers, enabling scalable manufacturing of iPSCs, MSCs, NK cells, and T cells.

What PBS Biotech does

PBS Biotech, Inc., founded in 2006 and headquartered in Camarillo, California, designs and manufactures single-use bioreactor systems based on its patented Vertical-Wheel impeller technology for the cell therapy industry. The platform uses a vertically-oriented, bi-directional impeller rotating via magnetic coupling around a fixed shaft to deliver low-shear, homogeneous mixing that is CFD-validated (ANSYS Fluent, MStar, STAR-CCM+) to scale linearly from 60mL to 80L across the PBS-Mini 0.1, PBS-Mini 0.5, MiniPRO (multi-parallel), PBS-3, PBS-15, and PBS-80 product family. Products are assembled in-house at a 63,800 sq. ft. ISO 9001:2015 facility, with single-use vessels gamma-irradiated and product-contact materials meeting USP Class VI / ISO 10993; the proprietary Hello UI software supports 21 CFR Part 11 cGMP requirements. Named end users include the University of Alberta, GeneFab, RoosterBio, and the Alberta Diabetes Institute, spanning iPSC, MSC, NK, and T-cell applications.

The company sells hardware on a quote-based enterprise motion to biopharmaceutical companies, CDMOs, and academic researchers, complemented by recurring consumables (single-use vessels, sensors, perfusion vessels, accessories) and professional services including Success Bundle consulting, 4-6 month contract process development engagements, and field service/IQ-OQ qualification. Pricing is anchored by Starter Packs publicly listed at $7,250 (Basic) to $18,750 (Premium) for 0.1L systems, with savings of 39-43% versus unbundled list, plus a Credit Redemption Program that awards 1 credit per $1 spent on PBS-Mini products (2023-2026) redeemable toward MiniPRO, PBS-3, or Success Bundles. GTM combines direct field sales (Sr. VP Global Sales, CCO) with an e-commerce storefront at shoppbsbiotech.com, supported by an Applications Engineering team and a multi-channel content marketing program (webinars, case studies, posters, conference presence at ISSCR, ISCT, ARM Meeting on the Mesa). Strategic partnerships include co-development integrations with Repligen (XCell ATF), GeneFab, STEMCELL Technologies, denovoMATRIX, CellGenix, and Masterflex, alongside financial backers Avego Management and BroadOak Capital Partners (cumulative disclosed equity approximately $57.5M across 2021, 2023, 2024, and 2025 rounds).

PBS Biotech firmographics

Firmographics
Name
PBS Biotech
Legal name
PBS Biotech, Inc.
Website
https://pbsbiotech.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
101–250 employees
Short description
PBS Biotech manufactures single-use Vertical-Wheel bioreactor systems (60mL to 80L) and provides process development services for cell therapy developers, CDMOs, and academic researchers, enabling scalable manufacturing of iPSCs, MSCs, NK cells, and T cells.
Ownership category
akta.pro rank

PBS Biotech industry classification

Industry
Product category
Single-Use Bioreactors for Cell Therapy Bioprocessing
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAG
Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers)
SECONDARYHLAGABAL
Process Development & Tech Transfer Services (CDMO)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAA
Cell Therapy CDMO (Autologous/Allogeneic Manufacturing)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)

Keywords

  • Single-use bioreactors
  • Cell therapy manufacturing
  • Bioprocess equipment
  • Process development services
  • Vertical-wheel mixing

Where PBS Biotech is headquartered

Location

Headquarters

HQ city
Camarillo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PBS Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

  1. Single-Use Bioreactor Hardware Systems: Sale of reusable electromechanical bioreactor housing units (Base Unit for PBS-Mini; instrument units for PBS-3, PBS-15, PBS-80). Hardware is sold directly to biopharma companies and CDMOs for cell therapy manufacturing. Price points vary by scale; quote-based pricing with publicly listed Starter Pack options starting at $7,250.
  2. Single-Use Vessels and Consumables: Recurring revenue from single-use bioreactor vessels (gamma-irradiated, double-bagged), perfusion vessels, sensors (single-use and reusable), accessories, and filters. Purchased alongside hardware systems and replenished regularly. PBS-Mini generates 1 credit per $1 spent redeemable toward larger systems.
  3. Process Development (CDO) Services: Contract process development services provided by Bioprocess Research & Development team using state-of-the-art onsite laboratory. Services include cell culture process development, optimization, scale-up, and characterization for iPSCs, MSCs, NK cells, T cells, and other therapeutic cell types. Typical contract duration 4-6 months. Supports customers from R&D through first-in-human clinical studies.
  4. Success Bundles (Consulting Packages): Personalized consulting packages (Basic, Enhanced, Premium) bundled with Starter Pack purchases or sold separately. Includes remote support, data analysis, process optimization guidance, and on-site application engineering visits. Credits earned through PBS-Mini purchases can be redeemed toward Success Bundles, PBS-3, or MiniPRO bioreactors.
  5. Field Service and Qualification: System installation, preventative maintenance, onsite support, instrument repair, IQ/OQ qualification protocols, software upgrades, and hardware conversions provided by Applications Engineers. Service Plans offered for MiniPRO, PBS-3, PBS-15, and PBS-80 bioreactors.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goBasic Starter Pack — $7,250 (0.1L) / $7,560 (0.5L), saving 39% vs. $11,950/$12,310 list price
Unit PricingPay-as-you-goEnhanced Starter Pack — $13,000 (0.1L) / $13,620 (0.5L), saving 41-42% vs. $22,400/$23,120 list price
Unit PricingPay-as-you-goPremium Starter Pack — $18,750 (0.1L) / $19,680 (0.5L), saving 42-43% vs. $32,850/$33,930 list price
Unit PricingPay-as-you-goBasic Success Bundle standalone — bundled pricing available when purchased with Starter Pack
Unit PricingPay-as-you-goEnhanced Success Bundle standalone — bundled pricing available when purchased with Starter Pack
Unit PricingPay-as-you-goPremium Success Bundle standalone — bundled pricing available when purchased with Starter Pack
Unit PricingMulti-year contractIndividual Bioreactor Systems — quote-based pricing

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

PBS Biotech product offering

Product offering

Core offering

PBS Biotech designs, manufactures, and sells single-use bioreactor systems based on its patented Vertical-Wheel impeller technology for the cell therapy industry, with working volumes spanning 60 mL to 80 L across the PBS-Mini, MiniPRO, PBS-3, PBS-15, and PBS-80 product families. The company also provides contracted process development (CDO) services, Success Bundle consulting packages, and field service to support customers scaling cell therapies from R&D through commercial manufacturing.

Product overview

PBS Biotech offers a scalable Vertical-Wheel bioreactor platform for cell therapy manufacturing spanning from 0.1L to 80L working volumes. The product family includes PBS-Mini (0.1 and 0.5L) for early-stage process development, MiniPRO for high-throughput parallel development, PBS-3 (3L) for mid-scale development and early clinical trials, PBS-15 (15L) for clinical stage production, and PBS-80 (80L) for commercial-scale manufacturing. All bioreactors share the proprietary Vertical-Wheel impeller technology enabling linear scalability and homogeneous mixing conditions. The platform is complemented by single-use vessels, perfusion accessories, Success Bundle consulting services, and contract process development (CDO) services for cell therapy optimization.

Differentiator

Problem solved

Functional benefit

Products and services

  • PBS-Mini 0.1 Bioreactor Entry-level single-use bioreactor supporting 60 to 100 mL working volumes with Vertical-Wheel mixing, designed for early-stage cell therapy development and scale-up path to larger bioreactors. Used by cell therapy developers and academic researchers in incubator-controlled environments.
  • PBS-Mini 0.5 Bioreactor Single-use bioreactor supporting 300 to 500 mL working volumes with a universal Base Unit and GMP-compliant materials for first-in-human clinical trials, designed for early-stage cell therapy development.
  • PBS-MiniPRO Bioreactor Multi-parallel bioreactor platform enabling simultaneous control of up to 24 cultures with real-time monitoring in a closed system, designed for high-throughput cell therapy process development and scale-up using Vertical-Wheel technology.
  • PBS-3 Bioreactor Mid-scale single-use bioreactor supporting 1.8 to 3 L working volumes with bioprocess control and monitoring capabilities, designed for bench-scale stem cell therapy process development and seamless transition from PBS-Mini.
  • PBS-15 Bioreactor Large-scale single-use bioreactor supporting 9 to 15 L working volumes with Adjustable Height Harvest Valve (AHHV) for medium exchange, sampling, and harvest, designed for clinical and commercial-scale stem cell therapy production.
  • PBS-80 Bioreactor Commercial-scale single-use bioreactor supporting 40 to 80 L working volumes with Adjustable Height Harvest Valve (AHHV), designed for large-scale cell therapy production with reproducible scale-up from PBS-Mini process conditions.
  • PBS-Mini 0.5 Perfusion Single-Use Vessel Single-use vessel with integrated 60 μm PSC Perfusion Filter for controlled perfusion-based PSC cultures, providing built-in cell retention with dedicated feed and waste lines for contamination-free continuous perfusion.
  • PBS Starter Packs Entry-level curated solutions bundling PBS-Mini bioreactor systems, single-use vessels (0.1 L or 0.5 L), and a Success Bundle consulting package across three tiers (Basic, Enhanced, Premium) at 39-43% savings versus component list price.
  • Success Bundles Personalized consulting packages with three tiers (Basic remote support, Enhanced remote plus one site visit, Premium remote plus two site visits) that provide data analysis, optimization guidance, and access to PBS Bioprocess Research Team.
  • Process Development (CDO) Services Contracted process development services covering cell thawing/inoculation, seed train optimization, 3D expansion, differentiation, medium exchange, harvest, downstream processing, analytics, and tech transfer using the company's Vertical-Wheel platform. Typical contract duration is 4-6 months.

Companies that use PBS Biotech

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

PBS Biotech technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

PBS Biotech partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered strategic.

  • STEMCELL TechnologiesstrategicStrategic or Co-development PartnerPartnership announced on STEMCELL Technologies press release for robust scale-up of human pluripotent stem cell 3D cultures. Combines STEMCELL's cell culture media and reagents expertise with PBS Biotech's Vertical-Wheel bioreactor platform for optimized PSC culture scale-up.
  • GeneFabstrategicTechnology or IntegrationCollaboration demonstrated in published CAR-NK cell expansion case study using PBS Vertical-Wheel Bioreactors with Repligen's XCell ATF perfusion technology. GeneFab contributed process development expertise and demonstrated closed-system workflow for NK cell expansion at 100mL and 3L working volumes.
  • RepligenstrategicTechnology or IntegrationPartnership through XCell Alternating Tangential Flow (ATF2) filtration device integration with PBS Vertical-Wheel Bioreactors. Demonstrated in joint case study with GeneFab for CAR-NK cell expansion showing 2.6X greater cell yield with perfusion media exchange vs. fed-batch methods. Enables closed, scalable low-shear environment optimized for high-quality immune-cell production.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

PBS Biotech competitors and assessment

Company assessment

Broad incumbents

  • Lonza: Lonza is a leading cell therapy CDMO whose process development services and proprietary bioreactor approaches compete for the same allogeneic and CDMO budgets PBS Biotech targets, while also being a potential customer for Vertical-Wheel systems within Lonza's manufacturing network.

Direct peers

  • Sartorius: Sartorius' Biostat RM and Biostat B single-use bioreactors are the closest large-scale competitors to PBS Biotech's Vertical-Wheel platform, with comparable single-use vessel design and overlapping cell therapy and biopharma customer base.
  • Merck KGaA (MilliporeSigma): MilliporeSigma's Mobius CellReady and Mobius bioreactor systems are direct competitors to PBS Biotech's single-use platform, often bundled with Merck's media, buffers, and filtration products for cell therapy customers.
  • Cytiva: Cytiva's Xuri W25 cell expansion system and single-use bioreactor portfolio directly compete with PBS Biotech in cell therapy manufacturing, offering similar scale-up functionality with a much larger global service network and broader bioprocess portfolio.
  • ABEC: ABEC designs custom single-use bioreactors for cell therapy and viral vector applications at commercial scale, competing with PBS Biotech's PBS-15 and PBS-80 systems among larger allogeneic and CDMO customers.
  • Thermo Fisher Scientific: Thermo Fisher's HyPerforma and Nunc single-use bioreactor systems (acquired largely via the Finesse and Patheon portfolios) compete head-to-head with PBS Biotech for cell therapy manufacturing capital equipment, bundled with the company's media, filters, and services.
  • Eppendorf: Eppendorf's BioFlo 320 and BioFlo 120 bioreactor systems target process development and small-scale production for cell and gene therapy applications, overlapping with PBS-Mini and PBS-3 use cases among academic and biotech customers.
  • Pall Corporation (Danaher): Pall's Allegro STR single-use bioreactors and iCELLis fixed-bed systems compete with PBS Biotech in cell therapy and bioprocess applications, leveraging Pall's broader filtration and bioprocess consumables portfolio within Danaher.

Emerging players

  • Cellexus: Cellexus offers the CellMaker single-use bioreactor system targeting cell and gene therapy process development, similar in scale and customer profile to PBS Biotech's PBS-Mini line, though with a smaller commercial footprint.
  • Miltenyi Biotec: Miltenyi Biotec offers the Prodigy and Cocoon closed-system cell processing platforms that overlap with PBS Biotech's process development and small-scale manufacturing value proposition for autologous and allogeneic cell therapy developers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

PBS Biotech social profiles

Digital presence

PBS Biotech compliance and trust

Trust signal

Compliance2 records

PBS Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PBS Biotech leadership team

Management profile

Number of profiles

Profiles17 records

PBS Biotech funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PBS Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PBS Biotech

What does PBS Biotech do?

PBS Biotech designs, manufactures, and sells single-use bioreactor systems based on its patented Vertical-Wheel impeller technology for the cell therapy industry, with working volumes spanning 60 mL to 80 L across the PBS-Mini, MiniPRO, PBS-3, PBS-15, and PBS-80 product families. The company also provides contracted process development (CDO) services, Success Bundle consulting packages, and field service to support customers scaling cell therapies from R&D through commercial manufacturing.

Is PBS Biotech a public or private company?

PBS Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was PBS Biotech founded?

PBS Biotech was founded in 2006. It employs 101 to 250 people.

Where is PBS Biotech based?

PBS Biotech is headquartered in Camarillo, United States, in the North America region.

How does PBS Biotech make money?

Five revenue lines are on record. Single-Use Bioreactor Hardware Systems are the primary driver. The others are single-Use Vessels and Consumables, process Development (CDO) Services, success Bundles (Consulting Packages) and field Service and Qualification.

Who are PBS Biotech's main competitors?

Lonza is listed as a broad incumbent. Direct peers are Sartorius, Merck KGaA (MilliporeSigma), Cytiva, ABEC, Thermo Fisher Scientific, Eppendorf and Pall Corporation (Danaher). Emerging players are Cellexus and Miltenyi Biotec.

Does PBS Biotech have an API?

No public API is recorded for PBS Biotech.

What industry is PBS Biotech in?

PBS Biotech's product category is Single-Use Bioreactors for Cell Therapy Bioprocessing. Its primary akta.pro industry code is HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers), with a secondary code of HLAGABAL, Process Development & Tech Transfer Services (CDMO). Its NAICS code is 334516 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Machine MakerPBS Biotech Uses Rockwell Automation Technology to Scale Cell Therapy Development – Machine MakerPBS Biotech integrated Rockwell Automation's FactoryTalk software and Process Library into its MiniPRO multi-parallel bioreactor platform to automate process control for cell therapy development. The system supports up to 24 bioreactors and enables seamless technology transfer to clinical and commercial manufacturing. ARMI, an early adopter, noted streamlined integration for building larger manufacturing lines.Mirage NewsPBS Biotech Industrializes Cell Therapy Development with Rockwell AutomationPBS Biotech embedded Rockwell Automation's FactoryTalk software and Process Library into its MiniPRO multi-parallel bioreactor platform, enabling real-time process control and integration into a PlantPAx DCS. The partnership aims to address low-throughput workflows and variability in cell therapy development, with ARMI as an early adopter. The platform's performance matches larger-scale bioreactors, supporting predictable scale-up to GMP settings.MarketScreenerPBS Biotech Industrializes Cell Therapy Development with Rockwell Automation, IncPBS Biotech embedded Rockwell Automation technology into its MiniPRO multi-parallel bioreactor platform to accelerate cell therapy development and scale-up. The platform uses FactoryTalk software and integrates with PlantPAx DCS, with performance consistent to larger-scale Vertical-Wheel bioreactors.PR NewswirePBS Biotech Industrializes Cell Therapy Development with Rockwell AutomationPBS Biotech embedded Rockwell Automation technology into its MiniPRO multi-parallel bioreactor platform to accelerate cell therapy process development and scale-up. The platform uses FactoryTalk software and integrates with PlantPAx DCS, enabling industrial-grade control and GMP readiness. ARMI was an early adopter, citing streamlined system integration.BioProcess InternationalPBS to expand single-use bioreactor techPBS Biotech has closed a $10 million private funding round with BroadOak Capital Partners to expand its internal operations and capacity for cell therapy manufacturing. The investment supports the growth of PBS's Vertical-Wheel bioreactor technology, which the company claims offers superior scalability and homogeneous mixing compared to traditional stirred-tank systems.PR NewswirePBS Biotech Wins 2026 Cell Products Development of the Year AwardPBS Biotech was named Cell Therapy Products Development of the Year 2026 by Life Sciences Review, recognizing its Vertical-Wheel bioreactor technology for low-shear cell culture. The company's platform enables linear scalability from research to commercial manufacturing for sensitive cell types. PBS Biotech plans to expand its technology portfolio to support cell therapy commercialization.BioSpacePBS Biotech Unveils a Breakthrough Product for Cell Therapy Process Development at ISSCR, BostonPBS Biotech announced the launch of MiniPRO™, a multi-parallel bioreactor platform designed for high-throughput cell therapy process development, at the ISSCR symposium in Boston. The platform allows researchers to run up to 24 independent cultures with real-time control in a closed system, aiming to streamline early process development and scale-up. The product builds on PBS's Vertical-Wheel technology and targets the growing cell therapy manufacturing market.PR NewswirePBS Biotech Unveils a Breakthrough Product for Cell Therapy Process Development at ISSCR, BostonPBS Biotech announced the launch of MiniPRO™, a multi-parallel bioreactor platform designed for high-throughput cell therapy process development, at the ISSCR Symposium in Boston on December 2, 2025. The product enables simultaneous control of up to 24 independent cultures, supporting scalable and efficient process development with real-time monitoring and automation.PR NewswirePBS Biotech Appoints Martin Simonetti as Chief Executive Officer to Support Next Phase of GrowthPBS Biotech appointed Martin Simonetti as Chief Executive Officer effective October 27th, 2025, succeeding founder Dr. Brian Lee, who will transition to Chief Technology Officer while continuing as Chairman of the Board. Simonetti brings over 40 years of biotech industry experience, including C-suite leadership roles at VLST Corporation and Dendreon Corporation, as well as senior positions at Amgen and Genentech. The company, backed by investors Avego and BroadOak, positions this leadership transition to drive expansion in the rapidly growing cell therapy market.